I don't know or care if he's right on timing. The most substantive part of his article was clearly focused on manufacturing and the intricacies of how DCVax works. My takeaway was that zero barriers exist between the global rGBM and nGBM market except a large MAA application. If it's 1 million pages, 750K, 1.5, or 3 million in length really does not matter in any way as PIP and MIA clearly tell us it will be approved. If approval happens in June, July, October, September, October, November, or December of 2023 I will be very happy regardless. A few months means nothing to my investment timeline as I have no plans to sell my shares.
Bullish
Market Data 
Markets 
AI
